Celldex Therapeutics Inc. (CLDX)
NASDAQ · Healthcare
Celldex Therapeutics Inc. Revenue 2009–2025
Celldex Therapeutics Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Celldex Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 15000, a 97.84% decrease year-over-year.
- Celldex Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 4.6 M, a 4.33% increase year-over-year.
- Celldex Therapeutics Inc. annual revenue for 2025 was 1.5 M, a 77.99% decrease from 2024.
- Celldex Therapeutics Inc. annual revenue for 2024 was 7.0 M, a 1.99% increase from 2023.
- Celldex Therapeutics Inc. annual revenue for 2023 was 6.9 M, a 192.02% increase from 2022.
- Celldex Therapeutics Inc. annual revenue for 2022 was 2.4 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Celldex Therapeutics Inc. Market Cap — FAQ
Celldex Therapeutics Inc. (CLDX) market cap over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CLDX's market cap history?
The chart and table above show Celldex Therapeutics Inc.'s market cap by year and by quarter, including the growth rate.